Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment

Clinical trial NCT02367872 · COMPLETED

Trial details

NCT number: NCT02367872
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment Hepatic Impairment

Start date: 2015-03-01
Primary completion: 2016-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.